SEARCH

SEARCH BY CITATION

References

  • BAX, W.A., RENZENBRINK, G.J., VAN HEUVEN-NOLSEN, D., THIJSSEN, H.J.M., BOS, E. & SAXENA, P.R. (1993). 5-HT receptors mediating contractions of the isolated human coronary artery. Eur. J. Pharmacol., 239, 203210.
  • BAX, W.A., RENZENBRINK, G.J., VAN DER LINDEN, E.A., ZIJLSTRA, F.J., VAN HEUVEN-NOLSEN, D., FEKKES, D., BOS, E. & SAXENA, P.R. (1994). Low-dose aspirin inhibits platelet-induced contraction of the human isolated coronary artery; a role for additional 5-HT receptor antagonism against coronary vasospasm? Circulation, 89, 623629.
  • BROWN, E.G., ENDERSBY, C.A., SMITH, R.N. & TALBOT, J.C.C. (1991). The safety and tolerability of sumatriptan: an overview. Eur. Neurol, 31, 339344.
  • CHESTER, A.H., ALLEN, S.P., TADJKARIMI, S. & YACOUB, M.H. (1993a). Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation 87, 874880.
  • CHESTER, A.H., MARTIN, G.R., BODELSSON, M., ARNEKLO-NOBIN, B., TADJKARIMI, S., TORNEBRANDT, K. & YACOUB, M.H. (1990). 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc. Res., 24, 932937.
  • CHESTER, A.H., O'NEIL, G.S., ALLEN, S.P., LUU, T.N., TADJKARIMI, S. & YACOUB, M.H. (1992). Effect of endothelin on normal and diseased human coronary arteries. Eur. J. Clin. Invest., 22, 210213.
  • CHESTER, A.H., O'NEIL, G.S. & YACOUB, M.H. (1993b). Sumatriptan and ischaemic heart disease. Lancet, 341, 14191420.
  • COCKS, T.M., KEMP, B.K., PRUNEAU, D. & ANGUS, J.A. (1993). Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Br. J. Pharmacol. 110, 360368.
  • CONNOR, H.E., FENIUK, W. & HUMPHREY, P.A. (1989). 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur. J. Pharmacol. 161, 9194.
  • DE BOER, A.C., TURPIE, A.G.G., BUTT, R.W., JOHNSTON, R.V. & GENTON, E. (1982). Platelet release and thromboxane synthesis in symptomatic coronary artery disease. Circulation, 66, 327333.
  • DE LEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97E102.
  • FERRARI, M.D. & SAXENA, P.R. (1993). Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol. Sci., 14, 129133.
  • HOUGHTON, L.A., FOSTER, J.M., WHORWELL, P.J., MORRIS, J. & FOWLER, P. (1994). Is chest pain after sumatriptan oesophageal in origin? Lancet, 344, 985986.
  • HUMPHREY, P.P.A., FENIUK, W., PERREN, M.J., CONNOR, H.E., OXFORD, A.W., COATES, I.H. & BUTINA, D. (1988). GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol. 94, 11231132.
  • KAUMANN, A.J., FRENKEN, M., POSIVAL, H. & BROWN, A.M. (1994). Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries; 5-HT1-like receptors resemble cloned 5-HT1Dβ receptors. Circulation 90, 11411153.
  • LIN, P.J., CHANG, C.-H., PERSON, P.J., TZEN, K.-Y., CHU, J.-J., CHANG, J.-P. & HSIEH, M.-J. (1993). Thromboxane A2: an endothelium-derived vasoconstrictor in human internal mammary arteries. Ann. Thorac. Surg. 56, 97100.
  • MacINTYRE, P.D., BHARGAVA, B., HOGG, K.J., GEMMILL, J.D. & HILLIS, W.S. (1992). Effect of subcutaneous sumatriptan, a selective 5-HT1-receptor agonist on central hemodynamics and the coronary circulation. Br. J. Clin. Pharmacol. 34, 541546.
  • MacLENNAN, S.J., BOLOFO, M.L. & MARTIN, G.R. (1993). Amplifying interactions between spasmogens in vascular smooth muscle. Biochem. Soc. Trans., 21, 11451150.
  • MACLENNAN, S.J. & MARTIN, G.R. (1992). Effect of the thromboxane A2-mimetic U46619 on 5-HT1-like and 5-HT2 receptor mediated contraction of the rabbit isolated femoral artery. Br. J. Pharmacol. 107, 418421.
  • SERNERI, G.G. NERI, ABBATE, R., GENSINI, G.F., PANETTA, A., CASOLO, G.C. & CARINI, M. (1983). TxA2 production by human arteries and veins. Prostaglandins 25, 753767.
  • OGLETREE, M.L., HARRIS, D.N., HEDBERG, A., NAKANE, M. & REID, J. (1986). SQ30.741, a selective TxA2-receptor antagonist in vitro. Pharmacologist 28, 186.
  • OHLSTEIN, E.H., BECK, G.R., Jr., DOUGLAS, S.A., NAMBI, P., LAGO, M.A., GLEASON, J.G., RUFFOLO, JR, R.R., FEUERSTEIN, G. & ELLIOTT, J.D. (1994). Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. J. Pharmacol. Exp. Ther., 271, 762768.
  • OTTERVANGER, J.P. (1996). Pharmacoepidemiology of sumatriptan. Cardiovascular adverse reactions to a new antimigrainous drug. Thesis, Erasmus University Rotterdam.
  • PLOSKER, G.L. & McTAVISH, D. (1994). Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs, 47, 622651.
  • RUBANYI, G.M., FRYE, R.L., HOLMES, D.R. & VANHOUTTE, P.M. (1987). Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease. J. Am. Coll. Cardiol., 9, 12431249.
  • SAHIN-ERDEMLI, I., HOYER, D., STOLL, A., SEILER, M.P. & SCHOEFFTER, P. (1991). 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery. Br. J. Pharmacol. 102, 386390.
  • SAXENA, P.R. & TFELT-HANSEN, P. (1993). Sumatriptan. In The Headaches, ed. Olesen, J., Tfelt-Hansen, P. & Welch, K.M.A. pp. 329341. New York: Raven Press, Ltd.
  • SCHILD, H.O. (1957). Drug antagonism and pAx. Pharmacol. Rev. 9, 242246.
  • STEEL, R.G.D. & TORRIE, J.H. (1980). Principles and Procedures of Statistics. A Biomedical Approach. 2nd. edn., Tokyo: McGraw-Hill Kogakusha Ltd.
  • TADA, M., KUZEYA, T., INOUE, M., KODAMA, K., MISHIMA, M., YAMADA, M., INUI, M. & ABE, H. (1981). Elevation of thromboxane B2 levels in patients with classic and variant angina pectoris. Circulation 64, 11071115.
  • TADIPATRI, S., VAN HEUVEN-NOLSEN, D., FENIUK, W. & SAXENA, P.R. (1991). Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery. Br. J. Pharmacol., 104, 887894.
  • TUCA, J.O., PLANAS, J.M. & PARELLADA, P.P. (1989). Increase in PGE2 and TxA2 in the saliva of common migraine patients. Action of calcium channel blockers. Headache 29, 498501.
  • WILLET, F., CURZEN, N., ADAMS, J. & ARMITAGE, M. (1992). Coronary vasospasm induced by subcutaneous sumatriptan. Br. Med. J., 304, 1415.
  • YANG, Z., RICHARD, V., VON SEGESSER, L., BAUER, E., STULZ, P., TURINA, M. & LÜSCHER, T.F. (1990). Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries; a new mechanism of vasospasm? Circulation, 82, 188195.
  • YILDIZ, O. & TUNCER, M. (1995). Amplification of responses to sumatriptan by various agonists in rabbit isolated iliac artery. J. Cardiovasc. Pharmacol., 25, 508510.
  • ZIJLSTRA, F.J. & VINCENT, J.E. (1984). Determination of leuko-trienes and prostaglandins in [14C]arachidonic acid labelled human lung tissue by high-performance liquid chromatography and radioimmunoassay. J. Chromatography 311, 3950.